If solution with particulates is administered, the particulates could pass through the catheter and lead to local inflammation, mechanical disruption of tissue or an immune response to the particulate. In some cases, it may cause a delay in therapy.
Hospira has not received any adverse events reports associated with this issue.
More Articles on Recalls:
What the Increase in Device Recalls Means for Hospitals
14 Device Recalls in 2014
Medical Device Recalls Increased 97% Over Past 10 Years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
